CytoSorbents Corp (CytoSorbents) is a company that focuses on developing and providing blood purification technologies. The company carries out the research, development, and commercialization of hemoadsorption products designed to remove harmful substances from the blood. Its major products include CytoSorb, PuriFi, ECOS, and VetResQ. These products are used by healthcare professionals in critical care, cardiovascular, liver, and kidney applications to manage conditions like sepsis, liver failure, and trauma. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. It has operations in the US and Germany. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CytoSorbents Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- CytoSorbents Corp Company Overview
- CytoSorbents Corp Company Snapshot
- CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview
- CytoSorbents Corp - Pipeline Analysis Overview
- CytoSorbents Corp - Key Facts
- CytoSorbents Corp - Major Products and Services
- CytoSorbents Corp Pipeline Products by Development Stage
- CytoSorbents Corp Ongoing Clinical Trials by Trial Status
- CytoSorbents Corp Pipeline Products Overview
- BetaSorb
- BetaSorb Product Overview
- ContrastSorb
- ContrastSorb Product Overview
- CST 301
- CST 301 Product Overview
- CytoSorb
- CytoSorb Product Overview
- CytoSorb Clinical Trial
- CytoSorb-XL
- CytoSorb-XL Product Overview
- DrugSorb-ATR
- DrugSorb-ATR Product Overview
- HemoDefend BGA
- HemoDefend BGA Product Overview
- HemoDefend RBC
- HemoDefend RBC Product Overview
- K+ontrol
- K+ontrol Product Overview
- CytoSorbents Corp - Key Competitors
- CytoSorbents Corp - Key Employees
- CytoSorbents Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- CytoSorbents Corp, Recent Developments
- Dec 10, 2025: CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
- Nov 11, 2025: CytoSorbents To Attend Jefferies Global Healthcare Conference In London
- Oct 30, 2025: CytoSorbents to Report Third Quarter 2025 Financial Results and Business Highlights
- Sep 16, 2025: CytoSorbents Provides DrugSorb-ATR Regulatory Update
- Aug 20, 2025: Cytosorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
- Jul 31, 2025: Cytosorbents Leads a New Era in Sepsis Treatment
- Jun 24, 2025: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR
- May 01, 2025: CytoSorbents Provides Regulatory Update for DrugSorb-ATR
- Apr 21, 2025: CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program
- Nov 04, 2024: CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview
- CytoSorbents Corp Pipeline Products by Equipment Type
- CytoSorbents Corp Pipeline Products by Indication
- CytoSorbents Corp Ongoing Clinical Trials by Trial Status
- CytoSorbents Corp, Key Facts
- CytoSorbents Corp, Major Products and Services
- CytoSorbents Corp Number of Pipeline Products by Development Stage
- CytoSorbents Corp Pipeline Products Summary by Development Stage
- CytoSorbents Corp Ongoing Clinical Trials by Trial Status
- CytoSorbents Corp Ongoing Clinical Trials Summary
- BetaSorb - Product Status
- BetaSorb - Product Description
- ContrastSorb - Product Status
- ContrastSorb - Product Description
- CST 301 - Product Status
- CST 301 - Product Description
- CytoSorb - Product Status
- CytoSorb - Product Description
- CytoSorb - COOLEY- Study: ACute on ChrOnic Liver FailurE Using the CYtosorb Device
- CytoSorb - Cytokine Adsorption in Patients with Acute-on-chronic Liver Failure (CYTOHEP) - A Single Center, Open-label, Randomized, Controlled Intervention Trial
- CytoSorb - Cytokine Filtration in Lung Transplantation - a Randomised, Controlled, Multicentre Clinical Trial (GLUSorb)
- CytoSorb - Cytosorb Modulation of Surgical Inflammation During LVAD Insertion
- CytoSorb - CytoSorb Treatment of Critically Ill Patients Registry: International Registry on the Use of CytoSorb in the Critical Care Setting
- CytoSorb - Development and Use of a Population Pharmacokinetic Model of Amikacin and Vancomycin for the Optimization of Dosing Regimens in Critically Ill Patients on Different Modalities of Extracorporeal Hemoadsorption
- CytoSorb - Effect of Haemoadsorption During Cardiopulmonary Bypass on Patients After Heart Transplantation
- CytoSorb - Effectivity of Extracorporeal Cytokine Adsorption (Cytosorb) as Additive Treatment of CAR-T Cell Associated Cytokine Release (CRS) Syndrome and Encephalopathy Syndrome (CRES)
- CytoSorb - Hemadsorption to Enhance Drug Elimination in Intoxications
- CytoSorb - Prevention of Vasoplegia with the Use of CytoSorb
- CytoSorb - Safe and Timely Antithrombotic Removal (STAR) Registry: International Registry on the Use of CytoSorb for Removal of Antithrombotic Agents in the Acute Hospital Setting
- CytoSorb-XL - Product Status
- CytoSorb-XL - Product Description
- DrugSorb-ATR - Product Status
- DrugSorb-ATR - Product Description
- HemoDefend BGA - Product Status
- HemoDefend BGA - Product Description
- HemoDefend RBC - Product Status
- HemoDefend RBC - Product Description
- K+ontrol - Product Status
- K+ontrol - Product Description
- CytoSorbents Corp, Key Employees
- CytoSorbents Corp, Subsidiaries
- Glossary
- CytoSorbents Corp Pipeline Products by Equipment Type
- CytoSorbents Corp Pipeline Products by Development Stage
- CytoSorbents Corp Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aethlon Medical Inc
- Biomatrica Inc
- HemoCleanse Technologies LLC
- NxStage Medical Inc
- Hologic Inc
